Stay updated on Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial page

  1. Check
    10 days ago
    Change Detected
    Summary
    The page adds Head and neck squamous cell carcinoma and related topics (MedlinePlus Genetics) and expands the list of locations, while removing several location blocks.
    Difference
    2%
    Check dated 2025-12-24T12:21:26.000Z thumbnail image
  2. Check
    18 days ago
    Change Detected
    Summary
    Removed the disease focus 'Head and neck squamous cell carcinoma' and the related topic 'MedlinePlus Genetics' from the page.
    Difference
    0.1%
    Check dated 2025-12-16T22:26:07.000Z thumbnail image
  3. Check
    25 days ago
    Change Detected
    Summary
    Added topic 'Head and neck squamous cell carcinoma' and related MedlinePlus Genetics links on the page.
    Difference
    0.1%
    Check dated 2025-12-09T19:48:47.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Publications section wording updated to state that publications are automatically filled from PubMed and may not be about the study, and the revision tag changed from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T14:33:26.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Deleted the government funding status notice from the page; no core trial information (eligibility criteria, interventions, outcomes) was changed.
    Difference
    0.2%
    Check dated 2025-11-18T07:26:00.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Added location: Tainan, Taiwan, 704, and removed location: Tainan City, Taiwan, 704 from the study locations.
    Difference
    0.0%
    Check dated 2025-11-11T03:16:38.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial page.